FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 660

FusionGeneSummary for ACVR2A_SUMO1

check button Fusion gene summary
Fusion gene informationFusion gene name: ACVR2A_SUMO1
Fusion gene ID: 660
HgeneTgene
Gene symbol

ACVR2A

SUMO1

Gene ID

92

7341

Gene nameactivin A receptor type 2Asmall ubiquitin-like modifier 1
SynonymsACTRII|ACVR2DAP1|GMP1|OFC10|PIC1|SENP2|SMT3|SMT3C|SMT3H3|UBL1
Cytomap

2q22.3-q23.1

2q33.1

Type of geneprotein-codingprotein-coding
Descriptionactivin receptor type-2Aactivin A receptor, type IIAsmall ubiquitin-related modifier 1GAP modifying protein 1SMT3 homolog 3SMT3 suppressor of mif two 3 homolog 1sentrinubiquitin-homology domain protein PIC1ubiquitin-like protein SMT3Cubiquitin-like protein UBL1
Modification date2018052320180523
UniProtAcc

P27037

P63165

Ensembl transtripts involved in fusion geneENST00000535787, ENST00000241416, 
ENST00000404590, ENST00000495775, 
ENST00000392246, ENST00000392245, 
ENST00000409368, ENST00000392244, 
ENST00000409712, ENST00000409181, 
ENST00000409498, ENST00000409205, 
ENST00000469034, 
Fusion gene scores* DoF score6 X 5 X 4=1202 X 2 X 1=4
# samples 62
** MAII scorelog2(6/120*10)=-1
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(2/4*10)=2.32192809488736
Context

PubMed: ACVR2A [Title/Abstract] AND SUMO1 [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotation
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneACVR2A

GO:0030509

BMP signaling pathway

18436533

HgeneACVR2A

GO:0032927

positive regulation of activin receptor signaling pathway

12665502

HgeneACVR2A

GO:0045648

positive regulation of erythrocyte differentiation

9032295

TgeneSUMO1

GO:0016925

protein sumoylation

11889051|14752048|15572661|15637059|15959518|17696781|19223394|21965678|24651376

TgeneSUMO1

GO:0031334

positive regulation of protein complex assembly

18579533

TgeneSUMO1

GO:0032436

positive regulation of proteasomal ubiquitin-dependent protein catabolic process

18408734

TgeneSUMO1

GO:0034605

cellular response to heat

11514557

TgeneSUMO1

GO:0043392

negative regulation of DNA binding

16626738

TgeneSUMO1

GO:0045759

negative regulation of action potential

19223394

TgeneSUMO1

GO:0045892

negative regulation of transcription, DNA-templated

15572661

TgeneSUMO1

GO:0050821

protein stabilization

21968017

TgeneSUMO1

GO:0071276

cellular response to cadmium ion

11514557

TgeneSUMO1

GO:1902260

negative regulation of delayed rectifier potassium channel activity

19223394


check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
TCGARVSARCTCGA-FX-A2QS-01AACVR2Achr2

148680680

+SUMO1chr2

203072044

-
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000535787ENST00000392246ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
In-frameENST00000535787ENST00000392245ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000535787ENST00000409368ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000535787ENST00000392244ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000535787ENST00000409712ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000535787ENST00000409181ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000535787ENST00000409498ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000535787ENST00000409205ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-5UTRENST00000535787ENST00000469034ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000241416ENST00000392246ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
In-frameENST00000241416ENST00000392245ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000241416ENST00000409368ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000241416ENST00000392244ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000241416ENST00000409712ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000241416ENST00000409181ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000241416ENST00000409498ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000241416ENST00000409205ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-5UTRENST00000241416ENST00000469034ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000404590ENST00000392246ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
In-frameENST00000404590ENST00000392245ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000404590ENST00000409368ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000404590ENST00000392244ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
Frame-shiftENST00000404590ENST00000409712ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000404590ENST00000409181ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000404590ENST00000409498ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-3UTRENST00000404590ENST00000409205ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
5CDS-5UTRENST00000404590ENST00000469034ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3CDSENST00000495775ENST00000392246ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3CDSENST00000495775ENST00000392245ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3CDSENST00000495775ENST00000409368ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3CDSENST00000495775ENST00000392244ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3CDSENST00000495775ENST00000409712ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3UTRENST00000495775ENST00000409181ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3UTRENST00000495775ENST00000409498ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-3UTRENST00000495775ENST00000409205ACVR2Achr2

148680680

+SUMO1chr2

203072044

-
intron-5UTRENST00000495775ENST00000469034ACVR2Achr2

148680680

+SUMO1chr2

203072044

-

Top

FusionProtFeatures for ACVR2A_SUMO1


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
ACVR2A

P27037

SUMO1

P63165

On ligand binding, forms a receptor complex consistingof two type II and two type I transmembrane serine/threoninekinases. Type II receptors phosphorylate and activate type Ireceptors which autophosphorylate, then bind and activate SMADtranscriptional regulators. Receptor for activin A, activin B andinhibin A. Mediates induction of adipogenesis by GDF6 (Bysimilarity). {ECO:0000250|UniProtKB:P27038,ECO:0000269|PubMed:1314589}. Ubiquitin-like protein that can be covalently attachedto proteins as a monomer or a lysine-linked polymer. Covalentattachment via an isopeptide bond to its substrates requires prioractivation by the E1 complex SAE1-SAE2 and linkage to the E2enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4,RANBP2 or CBX4. This post-translational modification on lysineresidues of proteins plays a crucial role in a number of cellularprocesses such as nuclear transport, DNA replication and repair,mitosis and signal transduction. Involved for instance intargeting RANGAP1 to the nuclear pore complex protein RANBP2.Covalently attached to the voltage-gated potassium channel KCNB1;this modulates the gating characteristics of KCNB1(PubMed:19223394). Polymeric SUMO1 chains are also susceptible topolyubiquitination which functions as a signal for proteasomaldegradation of modified proteins. May also regulate a network ofgenes involved in palate development. Covalently attached to ZFHX3(PubMed:24651376). {ECO:0000269|PubMed:18408734,ECO:0000269|PubMed:18538659, ECO:0000269|PubMed:19223394,ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:24651376,ECO:0000269|PubMed:9019411, ECO:0000269|PubMed:9162015}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for ACVR2A_SUMO1


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.
>In-frame_ACVR2A_ENST00000535787_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_320aa
MCNEKFSYFPEMEVTQPTSNPVTPKPPYYNILLYSLVPLMLIAGIVICAFWVYRHHKMAYPPVLVPTQDPGPPPPSPLLGLKPLQLLEVK
ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE
LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ

>In-frame_ACVR2A_ENST00000241416_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_428aa
MGAAAKLAFAVFLISCSSGAILGRSETQECLFFNANWEKDRTNQTGVEPCYGDKDKRRHCFATWKNISGSIEIVKQGCWLDDINCYDRTD
CVEKKDSPEVYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTPKPPYYNILLYSLVPLMLIAGIVICAFWVYRHHKMAYPPVLVPTQDPGP
PPPSPLLGLKPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH
EKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV

>In-frame_ACVR2A_ENST00000404590_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_428aa
MGAAAKLAFAVFLISCSSGAILGRSETQECLFFNANWEKDRTNQTGVEPCYGDKDKRRHCFATWKNISGSIEIVKQGCWLDDINCYDRTD
CVEKKDSPEVYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTPKPPYYNILLYSLVPLMLIAGIVICAFWVYRHHKMAYPPVLVPTQDPGP
PPPSPLLGLKPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH
EKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV


* Fusion transcript sequences (only coding sequence (CDS) region).
>In-frame_ACVR2A_ENST00000535787_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_961nt
ATGTGTAATGAAAAGTTTTCTTATTTTCCGGAGATGGAAGTCACACAGCCCACTTCAAATCCAGTTACACCTAAGCCACCCTATTACAAC
ATCCTGCTCTATTCCTTGGTGCCACTTATGTTAATTGCGGGGATTGTCATTTGTGCATTTTGGGTGTACAGGCATCACAAGATGGCCTAC
CCTCCTGTACTTGTTCCAACTCAAGACCCAGGACCACCCCCACCTTCTCCATTACTAGGTTTGAAACCACTGCAGTTATTAGAAGTGAAA
GCAAGGGGAAGATTTGGTTGTGTCTGGAAAGCCCAGTTGCTTAACGAATATGTGGCTGTCAAAATATTTCCAATACAGGACAAACAGTCA
TGGCAAAATGAATACGAAGTCTACAGTTTGCCTGGAATGAAGCATGAGAACATATTACAGTTCATTGGTGCAGAAAAACGAGGCACCAGT
GTTGATGTGGATCTTTGGCTGATCACAGCATTTCATGAAAAGGGTTCACTATCAGACTTTCTTAAGGCTAATGTGGTCTCTTGGAATGAA
CTGTGTCATATTGCAGAAACCATGGCTAGAGGATTGGCATATTTACATGAGGATATACCTGGCCTAAAAGATGGCCACAAACCTGCCATA
TCTCACAGGGACATCAAAAGTAAAAATGTGCTGTTGAAAAACAACCTGACAGCTTGCATTGCTGACTTTGGGTTGGCCTTAAAATTTGAG
GCTGGCAAGTCTGCAGGCGATACCCATGGACAGGTTGGTACCCGGAGGTACATGGCTCCAGAGGTATTAGAGGGTGCTATAAACTTCCAA
AGGGATGCATTTTTGAGGATAGATATGTATGCCATGGGATTAGTCCTATGGGAACTGGCTTCTCGCTGTACTGCTGCAGATGCTGGGAAT

>In-frame_ACVR2A_ENST00000241416_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_1285nt
ATGGGAGCTGCTGCAAAGTTGGCGTTTGCCGTCTTTCTTATCTCCTGTTCTTCAGGTGCTATACTTGGTAGATCAGAAACTCAGGAGTGT
CTTTTCTTTAATGCTAATTGGGAAAAAGACAGAACCAATCAAACTGGTGTTGAACCGTGTTATGGTGACAAAGATAAACGGCGGCATTGT
TTTGCTACCTGGAAGAATATTTCTGGTTCCATTGAAATAGTGAAACAAGGTTGTTGGCTGGATGATATCAACTGCTATGACAGGACTGAT
TGTGTAGAAAAAAAAGACAGCCCTGAAGTATATTTTTGTTGCTGTGAGGGCAATATGTGTAATGAAAAGTTTTCTTATTTTCCGGAGATG
GAAGTCACACAGCCCACTTCAAATCCAGTTACACCTAAGCCACCCTATTACAACATCCTGCTCTATTCCTTGGTGCCACTTATGTTAATT
GCGGGGATTGTCATTTGTGCATTTTGGGTGTACAGGCATCACAAGATGGCCTACCCTCCTGTACTTGTTCCAACTCAAGACCCAGGACCA
CCCCCACCTTCTCCATTACTAGGTTTGAAACCACTGCAGTTATTAGAAGTGAAAGCAAGGGGAAGATTTGGTTGTGTCTGGAAAGCCCAG
TTGCTTAACGAATATGTGGCTGTCAAAATATTTCCAATACAGGACAAACAGTCATGGCAAAATGAATACGAAGTCTACAGTTTGCCTGGA
ATGAAGCATGAGAACATATTACAGTTCATTGGTGCAGAAAAACGAGGCACCAGTGTTGATGTGGATCTTTGGCTGATCACAGCATTTCAT
GAAAAGGGTTCACTATCAGACTTTCTTAAGGCTAATGTGGTCTCTTGGAATGAACTGTGTCATATTGCAGAAACCATGGCTAGAGGATTG
GCATATTTACATGAGGATATACCTGGCCTAAAAGATGGCCACAAACCTGCCATATCTCACAGGGACATCAAAAGTAAAAATGTGCTGTTG
AAAAACAACCTGACAGCTTGCATTGCTGACTTTGGGTTGGCCTTAAAATTTGAGGCTGGCAAGTCTGCAGGCGATACCCATGGACAGGTT
GGTACCCGGAGGTACATGGCTCCAGAGGTATTAGAGGGTGCTATAAACTTCCAAAGGGATGCATTTTTGAGGATAGATATGTATGCCATG
GGATTAGTCCTATGGGAACTGGCTTCTCGCTGTACTGCTGCAGATGCTGGGAATGGAGGAAGAAGATGTGATTGAAGTTTATCAGGAACA

>In-frame_ACVR2A_ENST00000404590_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_1285nt
ATGGGAGCTGCTGCAAAGTTGGCGTTTGCCGTCTTTCTTATCTCCTGTTCTTCAGGTGCTATACTTGGTAGATCAGAAACTCAGGAGTGT
CTTTTCTTTAATGCTAATTGGGAAAAAGACAGAACCAATCAAACTGGTGTTGAACCGTGTTATGGTGACAAAGATAAACGGCGGCATTGT
TTTGCTACCTGGAAGAATATTTCTGGTTCCATTGAAATAGTGAAACAAGGTTGTTGGCTGGATGATATCAACTGCTATGACAGGACTGAT
TGTGTAGAAAAAAAAGACAGCCCTGAAGTATATTTTTGTTGCTGTGAGGGCAATATGTGTAATGAAAAGTTTTCTTATTTTCCGGAGATG
GAAGTCACACAGCCCACTTCAAATCCAGTTACACCTAAGCCACCCTATTACAACATCCTGCTCTATTCCTTGGTGCCACTTATGTTAATT
GCGGGGATTGTCATTTGTGCATTTTGGGTGTACAGGCATCACAAGATGGCCTACCCTCCTGTACTTGTTCCAACTCAAGACCCAGGACCA
CCCCCACCTTCTCCATTACTAGGTTTGAAACCACTGCAGTTATTAGAAGTGAAAGCAAGGGGAAGATTTGGTTGTGTCTGGAAAGCCCAG
TTGCTTAACGAATATGTGGCTGTCAAAATATTTCCAATACAGGACAAACAGTCATGGCAAAATGAATACGAAGTCTACAGTTTGCCTGGA
ATGAAGCATGAGAACATATTACAGTTCATTGGTGCAGAAAAACGAGGCACCAGTGTTGATGTGGATCTTTGGCTGATCACAGCATTTCAT
GAAAAGGGTTCACTATCAGACTTTCTTAAGGCTAATGTGGTCTCTTGGAATGAACTGTGTCATATTGCAGAAACCATGGCTAGAGGATTG
GCATATTTACATGAGGATATACCTGGCCTAAAAGATGGCCACAAACCTGCCATATCTCACAGGGACATCAAAAGTAAAAATGTGCTGTTG
AAAAACAACCTGACAGCTTGCATTGCTGACTTTGGGTTGGCCTTAAAATTTGAGGCTGGCAAGTCTGCAGGCGATACCCATGGACAGGTT
GGTACCCGGAGGTACATGGCTCCAGAGGTATTAGAGGGTGCTATAAACTTCCAAAGGGATGCATTTTTGAGGATAGATATGTATGCCATG
GGATTAGTCCTATGGGAACTGGCTTCTCGCTGTACTGCTGCAGATGCTGGGAATGGAGGAAGAAGATGTGATTGAAGTTTATCAGGAACA


* Fusion transcript sequences (Full-length transcript).
>In-frame_ACVR2A_ENST00000535787_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_1974nt
AGGAGACCGAAAACGCGGCCGAGCCCGGAGCCCGGAGCTGGAGCCAGAGCCTGGACCAGAACTTGGCCGCCGCCTGCACCGCCGCCGCCG
CTGCCGCCCGCCGCCCCTTCCCCGCGCCGCAGCCGCCTCGCCGCCACCGCCGCGAGCTCGGCCGCCAGTGGTCCTCGGACTTTAGGTGTC
TGGGTTGAAGACAGAACCAATCAAACTGGTGTTGAACCGTGTTATGGTGACAAAGATAAACGGCGGCATTGTTTTGCTACCTGGAAGAAT
ATTTCTGGTTCCATTGAAATAGTGAAACAAGGTTGTTGGCTGGATGATATCAACTGCTATGACAGGACTGATTGTGTAGAAAAAAAAGAC
AGCCCTGAAGTATATTTTTGTTGCTGTGAGGGCAATATGTGTAATGAAAAGTTTTCTTATTTTCCGGAGATGGAAGTCACACAGCCCACT
TCAAATCCAGTTACACCTAAGCCACCCTATTACAACATCCTGCTCTATTCCTTGGTGCCACTTATGTTAATTGCGGGGATTGTCATTTGT
GCATTTTGGGTGTACAGGCATCACAAGATGGCCTACCCTCCTGTACTTGTTCCAACTCAAGACCCAGGACCACCCCCACCTTCTCCATTA
CTAGGTTTGAAACCACTGCAGTTATTAGAAGTGAAAGCAAGGGGAAGATTTGGTTGTGTCTGGAAAGCCCAGTTGCTTAACGAATATGTG
GCTGTCAAAATATTTCCAATACAGGACAAACAGTCATGGCAAAATGAATACGAAGTCTACAGTTTGCCTGGAATGAAGCATGAGAACATA
TTACAGTTCATTGGTGCAGAAAAACGAGGCACCAGTGTTGATGTGGATCTTTGGCTGATCACAGCATTTCATGAAAAGGGTTCACTATCA
GACTTTCTTAAGGCTAATGTGGTCTCTTGGAATGAACTGTGTCATATTGCAGAAACCATGGCTAGAGGATTGGCATATTTACATGAGGAT
ATACCTGGCCTAAAAGATGGCCACAAACCTGCCATATCTCACAGGGACATCAAAAGTAAAAATGTGCTGTTGAAAAACAACCTGACAGCT
TGCATTGCTGACTTTGGGTTGGCCTTAAAATTTGAGGCTGGCAAGTCTGCAGGCGATACCCATGGACAGGTTGGTACCCGGAGGTACATG
GCTCCAGAGGTATTAGAGGGTGCTATAAACTTCCAAAGGGATGCATTTTTGAGGATAGATATGTATGCCATGGGATTAGTCCTATGGGAA
CTGGCTTCTCGCTGTACTGCTGCAGATGCTGGGAATGGAGGAAGAAGATGTGATTGAAGTTTATCAGGAACAAACGGGGGGTCATTCAAC
AGTTTAGTTTTAAAATTTGAGGGTCTGGACCAAAAGAAGAGGAATATCAGGTTGAAGTCAAGATGACAGATAAGGTGAGAGTAATGACTA
ACTCCAAAGATGGCTTCACTGAAGAAAAGGCATTTTAAGATTTTTTAAAAATCTTGTCAGAAGATCCCAGAAAAGTTCTAATTTTCATTA
GCAATTAATAAAGCTATACATGCAGAAATGAATACAACAGAACACTGCTCTTTTTGATTTTATTTGTACTTTTTGGCCTGGGATATGGGT
TTTAAATGGACATTGTCTGTACCAGCTTCATTAAAATAAACAATATTTGTAAAAATCATACTAATGCTTATTTTATTTTAATTGTATAGA
AAGAAAAAAATGCCTAAAATAAGGTTTTCTTGCATAAATACTGGAAATTGCACATGGTACAAATTTTTTCTTCATTACTGTACAGTGATG
ATGTTAATGACTTTGAAGCACTGAAAGTTACTGAAGTGCCTTCTGAATCAAGGATTTAATTAAGGCCACAATACCTTTTTAATACTCAGT

>In-frame_ACVR2A_ENST00000241416_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_2538nt
AGGAGACCGAAAACGCGGCCGAGCCCGGAGCCCGGAGCTGGAGCCAGAGCCTGGACCAGAACTTGGCCGCCGCCTGCACCGCCGCCGCCG
CTGCCGCCCGCCGCCCCTTCCCCGCGCCGCAGCCGCCTCGCCGCCACCGCCGCGAGCTCGGCCGCCAGTGGTCCTCGGACTTTAGGTGTC
TGGGTTGAAGGTCGGTCCGGACATCGGACCCAGTCAGTTCCCAGACTGTCCGGGCGGCAGCGGACGCCGCTGCCGCCGCCGCCTCTTCGT
CGCCTCAGCCTGGCGTTTTGTTCCGAGAGACGGGAGAGGCGAGCGGAGCTGACAGTGATTTTGACAGTGATTTAAACCCGCTTTTGTTGT
TGTTGGCTTTTCGTTGTTTGGTTTTGTGTGTTGTGCGTGTGTGTGGCGGTTTTTCCCCCGTGGTGCATTTTATTTTTTATCGTTGTGCTC
TTTTTTTTCTTTTTTTTTTTTAACCCAGTGAGCGTTTTTTTTTTTTTTTTTTTTTTTTTTTGGTCTGGGCTTCCGAATATGTTTTATGAC
GGTTGATTTTACACCAGGAGGTTTGTCTCCGAGGAAGACCCAGGGAACTGGATATCTAGCGAGAACTTCCTCCGGATTCCCCGGCGCCTC
GGGAAAATGGGAGCTGCTGCAAAGTTGGCGTTTGCCGTCTTTCTTATCTCCTGTTCTTCAGGTGCTATACTTGGTAGATCAGAAACTCAG
GAGTGTCTTTTCTTTAATGCTAATTGGGAAAAAGACAGAACCAATCAAACTGGTGTTGAACCGTGTTATGGTGACAAAGATAAACGGCGG
CATTGTTTTGCTACCTGGAAGAATATTTCTGGTTCCATTGAAATAGTGAAACAAGGTTGTTGGCTGGATGATATCAACTGCTATGACAGG
ACTGATTGTGTAGAAAAAAAAGACAGCCCTGAAGTATATTTTTGTTGCTGTGAGGGCAATATGTGTAATGAAAAGTTTTCTTATTTTCCG
GAGATGGAAGTCACACAGCCCACTTCAAATCCAGTTACACCTAAGCCACCCTATTACAACATCCTGCTCTATTCCTTGGTGCCACTTATG
TTAATTGCGGGGATTGTCATTTGTGCATTTTGGGTGTACAGGCATCACAAGATGGCCTACCCTCCTGTACTTGTTCCAACTCAAGACCCA
GGACCACCCCCACCTTCTCCATTACTAGGTTTGAAACCACTGCAGTTATTAGAAGTGAAAGCAAGGGGAAGATTTGGTTGTGTCTGGAAA
GCCCAGTTGCTTAACGAATATGTGGCTGTCAAAATATTTCCAATACAGGACAAACAGTCATGGCAAAATGAATACGAAGTCTACAGTTTG
CCTGGAATGAAGCATGAGAACATATTACAGTTCATTGGTGCAGAAAAACGAGGCACCAGTGTTGATGTGGATCTTTGGCTGATCACAGCA
TTTCATGAAAAGGGTTCACTATCAGACTTTCTTAAGGCTAATGTGGTCTCTTGGAATGAACTGTGTCATATTGCAGAAACCATGGCTAGA
GGATTGGCATATTTACATGAGGATATACCTGGCCTAAAAGATGGCCACAAACCTGCCATATCTCACAGGGACATCAAAAGTAAAAATGTG
CTGTTGAAAAACAACCTGACAGCTTGCATTGCTGACTTTGGGTTGGCCTTAAAATTTGAGGCTGGCAAGTCTGCAGGCGATACCCATGGA
CAGGTTGGTACCCGGAGGTACATGGCTCCAGAGGTATTAGAGGGTGCTATAAACTTCCAAAGGGATGCATTTTTGAGGATAGATATGTAT
GCCATGGGATTAGTCCTATGGGAACTGGCTTCTCGCTGTACTGCTGCAGATGCTGGGAATGGAGGAAGAAGATGTGATTGAAGTTTATCA
GGAACAAACGGGGGGTCATTCAACAGTTTAGTTTTAAAATTTGAGGGTCTGGACCAAAAGAAGAGGAATATCAGGTTGAAGTCAAGATGA
CAGATAAGGTGAGAGTAATGACTAACTCCAAAGATGGCTTCACTGAAGAAAAGGCATTTTAAGATTTTTTAAAAATCTTGTCAGAAGATC
CCAGAAAAGTTCTAATTTTCATTAGCAATTAATAAAGCTATACATGCAGAAATGAATACAACAGAACACTGCTCTTTTTGATTTTATTTG
TACTTTTTGGCCTGGGATATGGGTTTTAAATGGACATTGTCTGTACCAGCTTCATTAAAATAAACAATATTTGTAAAAATCATACTAATG
CTTATTTTATTTTAATTGTATAGAAAGAAAAAAATGCCTAAAATAAGGTTTTCTTGCATAAATACTGGAAATTGCACATGGTACAAATTT
TTTCTTCATTACTGTACAGTGATGATGTTAATGACTTTGAAGCACTGAAAGTTACTGAAGTGCCTTCTGAATCAAGGATTTAATTAAGGC
CACAATACCTTTTTAATACTCAGTGTTCTGTTTTTTTAAAAACTTGATATTCCTGTATGGTGCATATATGATACAGTTACCTAATCATGT

>In-frame_ACVR2A_ENST00000404590_chr2_148680680_+_SUMO1_ENST00000392245_chr2_203072044_-_2072nt
GCCGCCCCTTCCCCGCGCCGCAGCCGCCTCGCCGCCACCGCCGCGAGCTCGGCCGCCAGTGGTCCTCGGACTTTAGGTGTCTGGGTTGAA
GGAGGTTTGTCTCCGAGGAAGACCCAGGGAACTGGATATCTAGCGAGAACTTCCTCCGGATTCCCCGGCGCCTCGGGAAAATGGGAGCTG
CTGCAAAGTTGGCGTTTGCCGTCTTTCTTATCTCCTGTTCTTCAGGTGCTATACTTGGTAGATCAGAAACTCAGGAGTGTCTTTTCTTTA
ATGCTAATTGGGAAAAAGACAGAACCAATCAAACTGGTGTTGAACCGTGTTATGGTGACAAAGATAAACGGCGGCATTGTTTTGCTACCT
GGAAGAATATTTCTGGTTCCATTGAAATAGTGAAACAAGGTTGTTGGCTGGATGATATCAACTGCTATGACAGGACTGATTGTGTAGAAA
AAAAAGACAGCCCTGAAGTATATTTTTGTTGCTGTGAGGGCAATATGTGTAATGAAAAGTTTTCTTATTTTCCGGAGATGGAAGTCACAC
AGCCCACTTCAAATCCAGTTACACCTAAGCCACCCTATTACAACATCCTGCTCTATTCCTTGGTGCCACTTATGTTAATTGCGGGGATTG
TCATTTGTGCATTTTGGGTGTACAGGCATCACAAGATGGCCTACCCTCCTGTACTTGTTCCAACTCAAGACCCAGGACCACCCCCACCTT
CTCCATTACTAGGTTTGAAACCACTGCAGTTATTAGAAGTGAAAGCAAGGGGAAGATTTGGTTGTGTCTGGAAAGCCCAGTTGCTTAACG
AATATGTGGCTGTCAAAATATTTCCAATACAGGACAAACAGTCATGGCAAAATGAATACGAAGTCTACAGTTTGCCTGGAATGAAGCATG
AGAACATATTACAGTTCATTGGTGCAGAAAAACGAGGCACCAGTGTTGATGTGGATCTTTGGCTGATCACAGCATTTCATGAAAAGGGTT
CACTATCAGACTTTCTTAAGGCTAATGTGGTCTCTTGGAATGAACTGTGTCATATTGCAGAAACCATGGCTAGAGGATTGGCATATTTAC
ATGAGGATATACCTGGCCTAAAAGATGGCCACAAACCTGCCATATCTCACAGGGACATCAAAAGTAAAAATGTGCTGTTGAAAAACAACC
TGACAGCTTGCATTGCTGACTTTGGGTTGGCCTTAAAATTTGAGGCTGGCAAGTCTGCAGGCGATACCCATGGACAGGTTGGTACCCGGA
GGTACATGGCTCCAGAGGTATTAGAGGGTGCTATAAACTTCCAAAGGGATGCATTTTTGAGGATAGATATGTATGCCATGGGATTAGTCC
TATGGGAACTGGCTTCTCGCTGTACTGCTGCAGATGCTGGGAATGGAGGAAGAAGATGTGATTGAAGTTTATCAGGAACAAACGGGGGGT
CATTCAACAGTTTAGTTTTAAAATTTGAGGGTCTGGACCAAAAGAAGAGGAATATCAGGTTGAAGTCAAGATGACAGATAAGGTGAGAGT
AATGACTAACTCCAAAGATGGCTTCACTGAAGAAAAGGCATTTTAAGATTTTTTAAAAATCTTGTCAGAAGATCCCAGAAAAGTTCTAAT
TTTCATTAGCAATTAATAAAGCTATACATGCAGAAATGAATACAACAGAACACTGCTCTTTTTGATTTTATTTGTACTTTTTGGCCTGGG
ATATGGGTTTTAAATGGACATTGTCTGTACCAGCTTCATTAAAATAAACAATATTTGTAAAAATCATACTAATGCTTATTTTATTTTAAT
TGTATAGAAAGAAAAAAATGCCTAAAATAAGGTTTTCTTGCATAAATACTGGAAATTGCACATGGTACAAATTTTTTCTTCATTACTGTA
CAGTGATGATGTTAATGACTTTGAAGCACTGAAAGTTACTGAAGTGCCTTCTGAATCAAGGATTTAATTAAGGCCACAATACCTTTTTAA
TACTCAGTGTTCTGTTTTTTTAAAAACTTGATATTCCTGTATGGTGCATATATGATACAGTTACCTAATCATGTTGAATAAATGGGCATG


Top

FusionGenePPI for ACVR2A_SUMO1


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors
ACVR2ASYNJ2BP, INHBA, INHA, GDF5, ENG, INHBB, BMP6, ACVR1B, BMP7, MAGI2, IGSF1, ERBB2IP, PEG10, ACVR1, GDF2, BMP10, TGFBR2, GINM1, PTGER3, HEPACAM2, LDLRAD4, DAXX, LRRIQ1, HAVCR2, MRAP2, PCDHAC1, DAAM2, C16orf58, TLR2, RNF11, TNFRSF10ASUMO1FAS, C11orf65, SP100, TNFRSF1A, UBE2I, PIAS1, PIAS2, HIPK2, TDP2, TOPORS, RANGAP1, SAE1, UBA2, DAXX, PML, TP53, TP73, SUMO1, CHD3, HIPK3, TDG, TOE1, DNMT3B, RAD51, RAD52, SENP2, TOP2B, SALL1, MX1, BRCA1, CHAF1A, MITF, JUN, SMAD4, NCOR2, RPS3, TSC22D3, PAX6, TRIM5, KAT5, RWDD3, DNM1, ATXN7, USP25, RNF4, MUL1, GLP1R, NR3C1, ZBTB16, YAP1, MDM2, TP63, ETV6, NR3C2, USPL1, PIAS3, ZCCHC12, CASP2, SATB1, TRPS1, PARK7, ATXN3, PPIL3, PRDX5, SULT1A1, SSSCA1, RNF111, CASP8AP2, SIMC1, UIMC1, HNRNPK, VCP, MYB, NFE2L2, BIRC3, RANBP2, ZCCHC7, ZMYM5, ZMYM2, ZHX1, SETX, BLM, WRN, PIAS4, C18orf25, SENP1, PTGS2, ARPC1B, ARPC2, ARPC4, PRKACB, FOXM1, SENP6, ATXN1, ATF2, PHC1, HNRNPC, SOX2, TFCP2, HGS, TRAF4, ZBTB6, RAD54L2, RAD54B, ZBTB26, CARD9, GMCL1, FAM118B, RHOXF2, FBF1, MAPK1IP1L, DTX2, EDARADD, CCDC67, SUMO1P1, CUL7, OBSL1, ZNF451, BUB1B, NR1H4, PKM, UBC, PARK2, MTOR, ZMYM3, PFDN2, PSMD2, PABPC1, KLF5, IFI16, EWSR1, IKZF3, KPNB1, NUP153, NUP107, SEH1L, SLX4, CDC5L, CREBBP, PCNA, FOXA1, PSIP1, HSF1, RNF168


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for ACVR2A_SUMO1


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

RelatedDiseases for ACVR2A_SUMO1


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneACVR2AC0920269Microsatellite Instability1CTD_human
TgeneSUMO1C0008924Cleft Lip1CTD_human
TgeneSUMO1C0008925Cleft Palate1CTD_human
TgeneSUMO1C0027626Neoplasm Invasiveness1CTD_human